, DNA. Am J Obstet Gynecol, vol.211, issue.4, pp.365-366, 2014.

A. Benachi, A. Letourneau, P. Kleinfinger, M. V. Senat, E. Gautier et al., Performance and indication of detection of trisomies 21, 18 and 13 in France by the analysis of fetal DNA in maternal blood, J Gynecol Obstet Biol Reprod, vol.45, issue.6, pp.633-673, 2015.

T. Rousseau, E. Amar, C. Ferdynus, C. Thauvin-tap, J. B. Gouyon et al., Variations in the prevalence of Down syndrome in the French population between 1978 and, J Gynecol Obstet Biol Reprod, vol.39, issue.4, pp.290-296, 2005.

F. Malone, J. A. Canick, R. H. Ball, D. A. Nyberg, C. H. Comstock et al., First-trimester or second-trimester screening, or both, for Down's syndrome, N Engl J Med, vol.353, pp.2001-2012, 2005.

M. M. Gil, M. S. Quezada, R. Revello, R. Akolekar, and K. H. Nicolaides, Analysis of Cell-Free DNA in Maternal Blood Screening for Fetal Aneuploidies: Updated Meta-Analysis, Ultrasound in Obstetrics & Gynecology, vol.45, issue.3, pp.249-66, 2015.

P. Mandel and P. Metais, The nucleic acids of blood plasma in humans, CR Academic Paris, vol.142, pp.241-243, 1948.

M. Korabecna, S. Opatrna, J. Wirth, K. Rulcova, J. Eiselt et al., C ell-free plasma DNA during peritoneal dialysis and hemodialysis in patients with chronic kidney disease, Ann NY Acad Sci, vol.1137, pp.296-301, 2008.

H. Schwarzenbach, D. S. Hoon, and K. Pantel, Cell-free nucleic acids as biomarkers in cancer patients, Nat Rev Cancer, vol.11, pp.426-463, 2011.

M. E. Norton, B. Jacobsson, G. K. Swamy, L. C. Laurent, and A. C. Ranzini, Cell-free DNA analysis for noninvasive examination of trisomy, N Engl J Med, 2015.

T. M. Livergood, K. A. Lechien, and A. S. Trudell, Obesity and cell-free DNA "no calls": is there an optimal gestational age at time of sampling?, Am J Obstet Gynecol, vol.216, issue.4, pp.413-414, 2017.

V. Bibliographiques-1.-down and J. , Observations on an ethnic Classification of idiots. London Hospital Reports

N. J. Roizen and D. Patterson, Down's syndrome. Lancet, 2003.

S. L. Sherman, E. G. Allen, L. H. Bean, and S. B. Freeman, Epidemiology of Down syndrome, Ment Retard Dev Disabil Res Rev, vol.13, issue.3, pp.221-228, 2007.

K. H. Nicolaides, M. L. Brizot, and R. J. Snijders, Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy, Br J Obstet Gynaecol, vol.101, pp.782-786, 1994.

P. P. Pandya, R. J. Snijders, and S. P. Johnson, Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation, Br J Obstet Gynaecol, vol.102, pp.957-962, 1995.

K. H. Nicolaides, R. J. Snijders, and C. M. Gosden, Ultrasonographically detectable markers of fetal chromosomal abnormalities, Lancet, vol.340, pp.704-707, 1992.

R. J. Snijders, P. Noble, N. Sebire, A. Souka, and K. H. Nicolaides, UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchaltranslucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group, Lancet, vol.352, issue.9125, pp.343-349, 1998.

M. Agathokleous, P. Chaveeva, L. Poon, P. Kosinski, and K. H. Nicolaides,

, Meta-analysis of second-trimester markers for trisomy 21, Ultrasound Obstet Gynecol, vol.41, issue.3, pp.247-61, 2013.

D. A. Nyberg, V. L. Souter, A. El-bastawissi, S. Young, F. Luthhardt et al., Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy, Ultrasound, vol.20, issue.10, pp.1053-63, 2001.

, Arrêté du 23 juin 2009 fixant les règles de bonnes pratiques en matière de dépistage et de diagnostic prénatals avec utilisation des marqueurs sériques maternels de la trisomie 21, Journal Officiel, vol.3, issue.152, 2009.

, Arrêté du 23 juin 2009 relatif à l'information, à la demande et au consentement de la femme enceinte à la réalisation d'une analyse portant sur les marqueurs sériques maternels et à la réalisation du prélèvement et des analyses en vue d'un diagnostic prénatal in utero prévues à l'article R. 2131-1 du code de la santé publique, Journal officiel, vol.3, issue.152, p.juillet, 2009.

, Arrêté du 19 février 2010 modifiant l'arrêté du 23 juin 2009 relatif à l'information, à la demande et au consentement de la femme enceinte à la réalisation d'une analyse portant sur les marqueurs sériques maternels et à la réalisation du prélèvement et des analyses en vue d'établir un diagnostic prénatal in utero prévues à l'article R. 2131-1 du code de la santé publique, Journal officiel, vol.2, issue.51, p.mars, 2010.

, Arrêté du 19 février 2010 modifiant l'arrêté du 23 juin 2009 fixant les règles de bonnes pratiques en matière de dépistage et de diagnostic prénatals avec, p.56

, utilisation des marqueurs sériques maternels de la trisomie 21, Journal officiel, vol.3, p.mars, 2010.

K. Spencer, J. N. Macri, D. A. Aitken, and J. M. Connor, Free beta-hCG as first-trimester marker for fetal trisomy, Lancet, vol.339, issue.8807, p.1480, 1992.

J. N. Macri, K. Spencer, K. Garver, P. D. Buchanan, B. Say et al., Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome, Prenat Diagn, vol.14, issue.2, pp.97-103, 1994.

F. Muller, C. Benattar, F. Audibert, N. Roussel, S. Dreux et al., First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers, Prenat Diagn, vol.23, issue.10, pp.833-839, 2003.

I. R. Merkatz, H. M. Nitowsky, J. N. Macri, and W. E. Johnson, An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities, Am J Obstet Gynecol, vol.148, issue.7, pp.886-94, 1984.

H. S. Cuckle, N. J. Wald, and S. G. Thompson, Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alphafetoprotein level, Br J Obstet Gynaecol, vol.94, issue.5, pp.387-402, 1987.

. Société-des-obstétriciens and C. Gynécologues-du, Interventions et techniques de diagnostic prénatal visant l'obtention d'un prélèvement foetal à des fins diagnostiques : risques et avantages pour la mère et le foetus, J Obstet Gynaecol Can, vol.37, issue.7, pp.1-7, 2015.

, Recommandations pour l'utilisation de l'ADN foetal circulant dans le sang maternel pour le dépistage de la trisomie 21, Communiqué du CNGOF du 17 juin, 2016.

H. Autorité-de-santé, Place des tests ADN libre circulant dans le sang maternel dans le dépistage de la trisomie 21 foetale, 2017.

Y. M. Lo, N. Corbetta, P. F. Chamberlain, V. Rai, I. L. Sargent et al., Presence of Fetal DNA in Maternal Plasma and Serum. Lancet, vol.350, issue.9076, pp.485-87, 1997.

E. Flori, B. Doray, and E. Gautier, Circulating cell-free fetal DNA in maternal serum appears to originate from cyto-and syncytio-trophoblastic cells. Case report, Hum Reprod, vol.19, pp.723-724, 2004.

M. Alberry, D. Maddocks, and M. Jones, Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast, Prenat Diagn, vol.27, pp.415-423, 2007.

J. Costa, A. Benachi, and E. Gautier, New strategy for prenatal diagnosis of Xlinked disorders, N Engl J Med, vol.346, issue.19, p.1502, 2002.

Y. M. Lo, N. M. Hjelm, C. Fidler, I. L. Sargent, M. F. Murphy et al., Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma, N Engl J Med, vol.339, issue.24, pp.1734-1742, 1998.

D. W. Bianchi, N. D. Avent, J. M. Costa, and C. E. Van-der-schoot, Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time, Obstet Gynecol, vol.106, pp.841-845, 2005.

J. H. Lim, M. J. Kim, S. Y. Kim, and K. Ho, Non-invasive prenatal detection of achondroplasia using circulating fetal DNA in maternal plasma, J Assist Reprod Genet, vol.28, issue.2, pp.167-72, 2011.

T. J. Jensen, T. Zwiefelhofer, R. C. Tim, Z. Dzakula, S. K. Kim et al., Highthroughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma, PloS One, vol.8, p.57381, 2013.

K. Spencer, V. Souter, N. Tul, R. Snijders, and K. H. Nicolaides, A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A, Ultrasound Obstet Gynecol, vol.13, issue.4, pp.231-238, 1999.

N. J. Wald and A. K. Hackshaw, Combining ultrasound and biochemistry in firsttrimester screening for Down's syndrome. Prenat Diagn, vol.17, pp.821-830, 1997.

R. Wapner, E. Thom, J. L. Simpson, E. Pergament, R. Silver et al., Firsttrimester screening for trisomies 21 and 18, N Engl J Med, 2003.

A. De and L. Biomédecine, Diagnostic prénatal 2013. Rapport médical et scientifique de l'assistance médicale à la procréation et de la génétique humaine en France

D. W. Bianchi, R. P. Rava, and A. J. Sehnert, DNA sequencing versus standard prenatal aneuploidy screening, N Engl J Med. 7 août, vol.371, issue.6, p.578, 2014.

M. E. Norton, R. J. Baer, R. J. Wapner, M. Kuppermann, L. L. Jelliffe-pawlowski et al., Cell free DNA versus Sequential Screening for the Detection of Fetal Chromosomal Abnormalities, Am J Obstet Gynecol, vol.214, pp.727-728, 2016.

A. Benachi, A. Letourneau, P. Kleinfinger, M. Senat, E. Gautier et al.,

, Performance et indication du dépistage des trisomies 21, 18 et 13 en France par l'analyse de l'ADN foetal dans le sang maternel, J Gynecol Obstet Biol Reprod, vol.45, issue.6, pp.633-673, 2016.

J. M. Costa, A. Letourneau, R. Favre, L. Bidat, J. Belaisch-allart et al., Cell-free fetal DNA versus maternal serum screening for trisomy 21 in pregnant women with and without assisted reproduction technology : a prospective interventional study, Genet Med, 2018.

M. M. Gil, M. Brik, C. Casanova, R. Martin-alonso, R. Verdejo et al., Screening for trisomies 21 and 18 in a Spanish public hospital : from the combined test to the cell free DNA test, J Matern Fetal Neonatal Med, vol.2016, pp.1-7

G. Ashoor, A. Syngelaki, L. Poon, J. Rezende, and K. H. Nicolaides, Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics, Ultrasound Obstet Gynecol, vol.41, pp.26-32, 2013.

L. Poon, T. Musci, K. Song, A. Syngelaki, and K. H. Nicolaides, Maternal Plasma Cell-Free Fetal and Maternal DNA at 11-13 Weeks' Gestation: Relation to Fetal and Maternal Characteristics and Pregnancy Outcomes, Fetal Diagn Ther, vol.33, pp.215-223, 2013.

E. Wang, A. Batey, C. Struble, T. Musci, K. Song et al., Gestational age and maternal weight effects on fetal cell-free DNA maternal plasma, Prenat Diagn, vol.33, pp.662-666, 2013.

L. Goff, C. Eschwege, E. Charles, M. Basdevant, and A. Obepi, Enquête épidémiologique nationale sur le surpoids et l'obésité, 2012.

J. Daigre, A. Atallah, J. Boissin, G. Jean-baptiste, P. Kangambega et al., The prevalence of overweight and obesity, and distribution of waist circumference, in adults and children in the French Overseas Territories: the PODIUM survey, Diabetes Metab, vol.38, issue.5, pp.404-415, 2012.

C. Hamon, S. Fanello, L. Catala, and E. Parot, Maternal obesity: effects on labor and delivery: Excluding other diseases that might modify obstetrical management, J Gynecol Obstet Biol Reprod, vol.34, issue.2, pp.109-123, 2005.

T. Partyka, Prévalence de l'obésité chez les femmes enceintes et les implications sur le déroulement de la grossesse dans la population sud-basse-terrienne : étude descriptive, rétrospective. Gynécologie et obstétrique, 2015.

, Invasive prenatal testing for aneuploidy, American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No, vol.88, pp.1459-1467, 2007.

N. Rose, Genetic Screening and the Obese Gravida, Clinical Obstetrics and Gynecology, vol.59, pp.140-147, 2016.

L. Thornburg, L. Tsai, L. Pressman, and M. Ho, Rates of completion of sonographic aneuploidy screening in obese gravidas, Am Journ. of Obstet. and Gynecol, vol.197, p.54, 2007.

M. Gandhi, . Fox, . Ns, K. Russo-stielglitz, M. E. Hanley et al., Effect of increased body mass index on first-trimester ultrasound examinationfor aneuploidy risk assessment, Obstet. Gynecol, vol.114, pp.856-859, 2009.

L. L. Thronburg, M. Mulconry, A. Post, A. Carpenter, D. Grace et al., Fetal nuchal translucency thickness evaluation in the overweight and obese gravid

, Ultrasound Obstet. Gynecol, vol.33, pp.665-669, 2009.

D. A. Krantz, T. W. Hallahan, V. J. Macri, and N. J. Macri, Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program, Prenat. Diagn, vol.25, pp.635-640, 2005.

L. M. Neveux, G. E. Palomaki, D. A. Larrivee, G. J. Knight, and J. E. Haddow, Refinements in managing maternal weight adjustment for interpreting prenatal screening results, Prenat. Diagn, vol.16, pp.1115-1119, 1996.

F. Fiorentino, S. Bono, F. Pizzuti, M. Mariano, A. Polverari et al., The importance of determing the limit of detection of non invasive prenatal testing methods, Prenat. Diagn, vol.36, pp.304-311, 2016.

P. Benn, H. Cuckle, and E. Pergament, Non invasive prenatal testing for aneuploidy : current status and future prospects, Ultrasound Obstet. Gynecol, vol.42, pp.15-33, 2013.

S. Ghanta, M. Mitchell, M. Ames, M. Hidestrand, P. Simpson et al., Non invasive prenatal detection of trisomy 21 using tandem signe nucleotide polymorphisms, PLoS One, vol.5, p.13184, 2010.